Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03047538Phase 4Withdrawn

Fixed Combination for Lipid and Blood Pressure Control

Role: collaborator

NCT02503566Not ApplicableUnknown

Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography

Role: collaborator

NCT02641652Phase 4Unknown

A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension

Role: collaborator

All 3 trials loaded